A Phase IIA FF/VI Study to Measure FeNO in Asthmatic Patients.

NCT02712047 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Fluticasone furoate (FF) (100 mcg)
DRUG: Vilanterol (VI) (25 mcg)
DRUG: Placebo

Sponsor

GlaxoSmithKline